Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Genomma Lab Internacional

Genomma Lab Internacional
1996 FOUNDED
PUBLIC STATUS
701-800 EMPLOYEES
LABB STOCK SYMBOL
3 INVESTMENTS
$0.99 SHARE PRICE (As of Wednesday Closing)
Description

Genomma Lab Internacional is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Personal Products
Other Industries
Pharmaceuticals
Stock Exchange
MEX
Primary Office
  • Samara Building
  • Antonio Dovalí Jaime No, 70 Piso 2, Col. Santa Fé, Del. Alvaro, Obregón, D.F.
  • CP 01210
  • Mexico

+52 01 00 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Genomma Lab Internacional’s full profile, request a free trial.

Genomma Lab Internacional Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.55 - $1.15 $1.04B $0.98 $0.05 1.92M 1.05B

Genomma Lab Internacional Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 1,258,003 846,877 1,325,312 1,326,250
Revenue 650,247 613,478 639,074 605,608
EBITDA 123,055 123,142 141,716 (60,784)
Net Income 48,169 57,708 67,683 (89,957)
Total Assets 969,397 919,807 808,845 758,196
Total Debt 302,278 298,849 239,466 281,603
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Genomma Lab Internacional Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Genomma Lab Internacional‘s full profile, request access.

Request full access to PitchBook

Genomma Lab Internacional Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00. 00000'0 000000 14-Jun-2018 000000000 00000 00 Pharmaceuticals
000000000 00000000 14-Jun-2018 000000000 00000 00 Buildings and Property
Marzam 30-Jun-2014 Merger/Acquisition 000.00 Pharmaceuticals
To view this company’s complete investment and acquisition history, request access »

Genomma Lab Internacional Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 30-Jun-2014 000000000000000000 000.00 Completed
  • 0000000 000 000000
To view this company’s complete exits history, request access »

Genomma Lab Internacional Executive Team (14)

Name Title Board
Seat
Contact
Info
Jorge Brake Chief Executive Officer
Hector González Board Member & Member of Audit Committee & Corporate Practices
Jorge Muñoz Board Member & Member of Audit Committee & Corporate Practices
Juan Alonso Board Member & Member of Audit Committee & Corporate Practices
César Jaramillo Executive Vice President, Marketing

4 Former Executives

You’re viewing 5 of 14 executives. Get the full list »

Genomma Lab Internacional Board Members (16)

Name Representing Role Since Contact
Info
0000é0 000000000 Self Independent Board Member 000 0000
0000000 0000000 Self Independent Board Member 000 0000
0000000 0000é0000 Self Independent Board Member 000 0000
000000 0000á000 Genomma Lab Internacional Board Member & Member of Audit Committee & Corporate Practices 000 0000
00000 00ñ00 Genomma Lab Internacional Board Member & Member of Audit Committee & Corporate Practices 000 0000

5 Former Board Members

You’re viewing 5 of 16 board members. Get the full list »